DYNLRB1 and listeriosis: Beyond the application of the BLP strains to prevent listeriosis in high-risk immunosuppressed populations, this receptor–ligand bioengineering strategy provides a pathogen-specific targeted approach to enhance the specificity of probiotic action and extend the health beneficial effects inherent to probiotic lactobacilli.